Model
Edge
Lineage Cell Therapeutics
0001310683
Filing Type
4
Filing Date
5/27/2024
Updated
5/28/24, 7:11 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership